BiotechnologyChemicalPharmaceutical Customer Partnership Meeting October 8, 2002 - PowerPoint PPT Presentation

About This Presentation
Title:

BiotechnologyChemicalPharmaceutical Customer Partnership Meeting October 8, 2002

Description:

Administrative Patent Judge. Board of Patent Appeals and Interferences. Biotechnology Division ... Ex parte Administrative Patent Judges. Donald Adams Lora ... – PowerPoint PPT presentation

Number of Views:36
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: BiotechnologyChemicalPharmaceutical Customer Partnership Meeting October 8, 2002


1
Biotechnology/Chemical/Pharmaceutical Customer
Partnership Meeting October 8, 2002
  • William F. Smith
  • Administrative Patent Judge
  • Board of Patent Appeals and Interferences

2
Biotechnology DivisionEx parte Administrative
Patent Judges
  • Donald Adams Lora Green
  • Eric Grimes Demetra Mills
  • Toni Scheiner William Smith
  • Sherman Winters

3
Biotechnology DivisionSupport Team
  • Dianne Maggard, Paralegal Specialist
  • Phone Number 703 305-4673
  • Dionne Murphy and JoAnne Burke, Legal Technicians
  • Lisa Bean and Marrilyn Johnson, Legal Instrument
    Examiners
  • Facsimile Number 703 308-6200

4
  • The Boards goal is to have no more than a six
    month inventory of ex parte appeals pending
    decision by September 30, 2003.
  • The Biotechnology Division is on track to meet
    that goal.

5
Case Load
  • As of October 1, 2002, all pre-2001-XXXX
    biotechnology appeals available for decision have
    been decided.
  • As of October 1, 2002, the Biotechnology Division
    had 324 cases on APJs dockets awaiting decision
    (on brief and cases which have been heard and
    awaiting decision) and 85 cases waiting to be
    heard.

6
Hearings
  • Hearing notices will be mailed 3-5 months ahead
    of date
  • After confirmations/waivers are received in
    initial set of cases, notices will be mailed in a
    second set of cases
  • Goal is to have at least 3 cases confirmed for
    each session

7
Hearings
  • Special hearings will be scheduled as needed and
    are normally scheduled by way of telephone.
  • Requests for rescheduling hearings should be made
    with an earlier date in mind.

8
Role of the Board
  • The Board shall, on written appeal of an
    applicant, review adverse decisions of examiners
    upon applications for patents 35 U.S.C.
    6(b)(emphasis added)
  • In other words, the Board serves as a board of
    review, not as a de novo examination tribunal.

9
How can you assist in preparing a record which
will facilitate a meaningful review of the
examiners decision?
  • Has prosecution/examination been conducted on the
    basis of determining the patentability of
    individual claims?
  • Or have the examiners actions and your
    responses been based upon The invention,
    Applicants invention, The instant invention
    etc.

10
Record
  • Focus must begin and remain on the claims
  • The name of the game is the claim. In re
    Hiniker Co., 47 USPQ2d 1523, 1529 (Fed. Cir.
    1998)
  • The sooner counsel and the examiner are
    discussing the patentability of individual
    claims, the sooner the patentability issues will
    be resolved.

11
Record contd
  • Remember claim construction in the USPTO differs
    from claim construction in an enforcement action.
  • As an initial matter the PTO applies to the
    verbiage of the proposed claims the broadest
    reasonable meaning of the words in their ordinary
    usage as they would be understood by one of
    ordinary skill in the art, taking into account
    whatever enlightenment by way of definitions or
    otherwise that may be afforded by the written
    description contained the applicants
    specification.
  • In re Morris, 127 F.3d 1048, 1054, 44 USPQ2d
    1023, 1027 (Fed. Cir. 1997)

12
Record contd
  • Has prosecution/examination been based upon the
    most complete set of facts available?
  • Are abstracts and/or untranslated documents
    relied upon by you or the examiner?
  • Rely upon source documents, translated if needed,
    at the earliest point in the examination process.

13
Record contd
  • Have formal matters been completed?
  • All petitions been decided?
  • Do you have a clear understanding of the status
    of all claims and the entry of all amendments
    after final rejection?

14
Record contd
  • Has all prior art of record been properly
    evaluated by you and the examiner?
  • The majority of panel remands to examiners and
    new rejections under 37 CFR 1.196(b) involve
    prior art of record.

15
Record contd
  • Has all the evidence you intend to rely upon in
    the appeal been entered and considered by the
    examiner?
  • Affidavits, declarations, or exhibits submitted
    after the case has been appealed will not be
    admitted without a showing of good and sufficient
    reasons why they were not earlier presented.
  • 37 CFR 1. 195

16
Appeal Brief
  • The formal requirements of the Appeal Brief are
    set forth in 37 CFR 1.192. See also MPEP
    Chapter 1200.
  • In preparing your Appeal Brief be aware that a
    mandatory appeal conference will be held in the
    Technical Center before an Examiners Answer is
    authorized.

17
Appeal Brief
  • Brief must contain your complete position.
  • Any arguments or authorities not included in
    the brief will be refused consideration by the
    Board of Patent Appeals and Interferences, unless
    good cause is shown.
  • 37 CFR 1.192(a)
  • Remember requirements of 37 CFR 1.195

18
Appeal Brief Summary of Invention
  • Focus on the requirements of individual claims.
    Be specific with references to specification and
    drawings to aid the reader in understanding the
    claims.

19
Appeal BriefSeparate argument of claims
  • Separate argument of claims
  • 1. If appropriate, simply state Claims do not
    stand or fall together.
  • 2. For every rejection, use headings in
    Argument section of brief to highlight
    argument.

20
Appeal BriefSeparate argument of claims, contd
  • For example in the Argument section a series of
    headings such as these can be used for each
    rejection
  • I. Arguments in response to enablement
    rejection.
  • A. Separate argument for claim 1.
  • B. Claims 2-3 are patentable for the
    reasons claim 1 is patentable.
  • C. Separate argument for claim 4.

21
Reply Brief
  • Two reasons to file
  • Point to arguments set forth in the Appeal Brief
    which the examiner overlooked.
  • Respond to new points of argument made in the
    Examiners Answer.
  • Remember the requirements of 37 CFR 1.195

22
Do you know where your case is?
  • Know where your case is located in the PTO after
    the briefing is concluded by using PAIR. The
    case should be forwarded to the Board within two
    months of the Reply Brief being acknowledged or
    the Examiners Answer being mailed if no Reply
    Brief is timely filed. MPEP 1210.

23
Summary
  • Make sure your case is ready for a decision on
    appeal.
  • Briefing should be focused on individual claims.
  • Make sure all evidence you need to prove your
    case is entered and considered by the examiner
    before the appeal.
  • Remember that the Board serves as a Board of
    review not as a de novo examination tribunal.
Write a Comment
User Comments (0)
About PowerShow.com